Terumo (TRUMY.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov13

Terumo released FY2026 Q2 earnings on November 12 After-Market EST, actual revenue USD 1.85 B (forecast USD 1.785 B), actual EPS USD 0.1598

00:00

Terumo released FY2026 Semi-Annual earnings on November 12 After-Market EST, actual revenue USD 3.647 B (forecast USD 3.482 B), actual EPS USD 0.3553

00:00

Nov12

Terumo Corporation Reports 5.2% Revenue Growth in H1 2026 Fiscal Year

06:47

Nov5

Terumo to Release FY2026 Q2 Earnings on November 12, After-Market EST, Forecast Revenue USD 1.736 B

00:10

Oct24

Terumo's OPUSWAVE® Dual Sensor Imaging System and DualView® Imaging Catheter Receive FDA Approval

12:00

Aug7

Terumo released FY2026 Q1 earnings on August 7 After-Market (EST), actual revenue USD 1.796 B (forecast USD 1.812 B), actual EPS USD 0.1959

23:00

Schedules & Filings

Schedules

Filings

Feb13

Earning Release(EST)

FY2026 Q3 Earning Release

Nov12

Earning Release(EST)

FY2026 Q2 Earning Release (USD) Revenue 1.85 B, Net Income 235.85 M, EPS 0.1598

Sep30

Distribution Plan(EST)

Cash dividend 0.1037 USD

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More